Abtrace
Company

Last deal

Amount

Non-equity Assistance

Stage

03.07.2023

Date

7

all rounds

$6.3M

Total amount

General

About Company
ABTrace is an AI-based company that scales medical expertise.

Industry

Sector :

Subsector :

Keywords :

founded date

24.08.2018

Number of employees

Company Type

For Profit

Last funding type

Non-equity Assistance

IPO status

Private

Description

ABTrace is a developer of a clinical decision-making tool that uses artificial intelligence and big data techniques to analyze patient data and provide insights that enable clinical decisions. Their tool aims to transform how chronic and long-term health conditions are detected, monitored, and treated. By reducing the misuse of antibiotics and improving treatment outcomes in real-time, healthcare institutions can reshape the delivery of primary care. ABTrace's focus on machine learning and clinical innovation is poised to make a significant impact on the healthcare industry.
Contacts

location

Phone number

Social url